@article{discovery10121114,
            year = {2021},
           title = {Single-dose intraoperative radiotherapy during lumpectomy for breast cancer: an innovative patient-centred treatment},
           month = {February},
            note = {This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.},
         journal = {British Journal of Cancer},
          author = {Vaidya, JS and Bulsara, M and Baum, M and Tobias, JS and TARGIT-A trial authors, {}},
             url = {https://doi.org/10.1038/s41416-020-01233-5},
        abstract = {In the randomised TARGIT-A trial, risk-adapted targeted intraoperative radiotherapy (TARGIT-IORT) during lumpectomy was non-inferior to whole-breast external beam radiotherapy, for local recurrence. In the long-term, no difference was found in any breast cancer outcome, whereas there were fewer deaths from non-breast-cancer causes. TARGIT-IORT should be included in pre-operative consultations with eligible patients.},
        keywords = {Breast cancer, Radiotherapy, Surgical oncology}
}